BriaCell Therapeutics Corp.
Support and Resistance Levels
Past performance
News About BCTXL
All events for BCTXL
All deals for BCTXL
Financial Ratios
Financial Statements
BCTXL vs Sector & Peers
About BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the development of novel immunotherapies to transform cancer care. It currently advancing its Bria-IMT™ targeted immunotherapy in combination with an immune check point inhibitor in a pivotal 1 Phase 3 study in metastatic breast cancer. The company was founded by Charles L. Wiseman and Isaac Benjamin Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada. Website briacell.com
Headquarters West Vancouver, BC, CA